22 May 2013
Keywords: first, phase, ii, data, argatroban, ami, texas
Article | 28 October 1996
Texas Biotechnology has presented the preliminary results from the first
of its three multicenter studies of Novastan (argatroban), a direct
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 November 1996
21 October 1996
11 November 1996
© 2013 thepharmaletter.com